WC
The company utilizes CRISPR technology and artificial intelligence algorithms to develop precision anti-cancer drugs through its Platform C and Platform H pipelines. This approach provides medical professionals with targeted treatment options to improve patient outcomes in cancer care.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company utilizes CRISPR technology and artificial intelligence algorithms to develop precision anti-cancer drugs through its Platform C and Platform H pipelines. This approach provides medical professionals with targeted treatment options to improve patient outcomes in cancer care.